Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib: Results from the ENESTFreedom study.
暂无分享，去创建一个
J. Radich | W. Wiktor-Jedrzejczak | F. Giles | G. Saglio | A. Hochhaus | T. Masszi | N. Gattermann | P. Coutre | H. Menssen | B. Martino | E. Conneally | A. Hellmann | S. Saussele | D. Ross | J. Stentoft | M. T. G. Casares | W. Deng | N. Krunic | V. Bédoucha | V. Gutiérrez